456 related articles for article (PubMed ID: 19161455)
1. Enantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose.
Nagilla R; Deshmukh DD; Copedge KJ; Miller S; Martin B; Bell EC; Duran SH; Ravis WR
J Vet Pharmacol Ther; 2009 Feb; 32(1):49-55. PubMed ID: 19161455
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective pharmacokinetics of ketorolac in calves after a single intravenous and oral dose.
Nagilla R; Deshmukh DD; Duran SH; Ravis WR
J Vet Pharmacol Ther; 2007 Oct; 30(5):437-42. PubMed ID: 17803736
[TBL] [Abstract][Full Text] [Related]
3. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
4. Stereospecific pharmacokinetics and toxicodynamics of ketorolac after oral administration of the racemate and optically pure enantiomers to the rat.
Jamali F; Lovlin R; Corrigan BW; Davies NM; Aberg G
Chirality; 1999; 11(3):201-5. PubMed ID: 10079499
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
6. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers.
McAleer SD; Majid O; Venables E; Polack T; Sheikh MS
J Clin Pharmacol; 2007 Jan; 47(1):13-8. PubMed ID: 17192497
[TBL] [Abstract][Full Text] [Related]
8. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits.
Hawkins MG; Taylor IT; Craigmill AL; Tell LA
J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs.
Pasloske K; Renaud R; Burger J; Conlon P
J Vet Pharmacol Ther; 1999 Oct; 22(5):314-9. PubMed ID: 10597535
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.
Cárceles CM; Font A; Espuny A; Fernández-Varón E; Serrano JM; Escudero E
J Vet Pharmacol Ther; 2005 Feb; 28(1):51-5. PubMed ID: 15720515
[TBL] [Abstract][Full Text] [Related]
12. Chiral kinetics and dynamics of ketorolac.
Mroszczak E; Combs D; Chaplin M; Tsina I; Tarnowski T; Rocha C; Tam Y; Boyd A; Young J; Depass L
J Clin Pharmacol; 1996 Jun; 36(6):521-39. PubMed ID: 8809637
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.
Lorier M; Magallanes L; Ibarra M; Guevara N; Vázquez M; Fagiolino P
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone.
Helton DR; Osborne DW; Pierson SK; Buonarati MH; Bethem RA
Drug Metab Dispos; 2000 Aug; 28(8):925-9. PubMed ID: 10901702
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy.
Prescilla RP; Frattarelli DA; Haritos D; Aranda JV; Edwards DJ
J Pediatr Hematol Oncol; 2004 Oct; 26(10):661-4. PubMed ID: 15454838
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ketorolac loaded to polyethylcyanoacrylate nanoparticles using UPLC MS/MS for its determination in rats.
Radwan MA; AlQuadeib BT; Aloudah NM; Aboul Enein HY
Int J Pharm; 2010 Sep; 397(1-2):173-8. PubMed ID: 20600724
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of magnolin in rats.
Kim NJ; Song WY; Yoo SD; Oh SR; Lee HK; Lee HS
Arch Pharm Res; 2010 Jun; 33(6):933-8. PubMed ID: 20607499
[TBL] [Abstract][Full Text] [Related]
18. Muscle tissue kinetics of oxytetracycline following intramuscular and oral administration at two dosages to giant freshwater shrimp (Macrobrachium rosenbergii).
Poapolathep A; Poapolathep S; Jermnak U; Imsilp K; Wannapat N; Sugita-Konishi Y; Kumagai S
J Vet Pharmacol Ther; 2008 Dec; 31(6):517-22. PubMed ID: 19000273
[TBL] [Abstract][Full Text] [Related]
19. Ketorolac tromethamine formulations: an overview.
Sinha VR; Kumar RV; Singh G
Expert Opin Drug Deliv; 2009 Sep; 6(9):961-75. PubMed ID: 19663721
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
Shi JM; Lai SG; Xu CJ; Duan GL; Li D
Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
